Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 2 |
Amazon
AMZN
|
+$734M |
| 3 |
Accenture
ACN
|
+$720M |
| 4 |
Broadcom
AVGO
|
+$617M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$521M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.55B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$677M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$578M |
| 4 |
T-Mobile US
TMUS
|
+$560M |
| 5 |
NVIDIA
NVDA
|
+$475M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.81% |
| 2 | Technology | 16.64% |
| 3 | Industrials | 7.27% |
| 4 | Healthcare | 7.2% |
| 5 | Consumer Discretionary | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5876
First US Bancshares
FUSB
$90.6M
| $28K | ﹤0.01% |
2,500
+1,500
| +150% | +$15.7K |
|
|
GPMT
5877
Granite Point Mortgage Trust
GPMT
$57.4M
| $28K | ﹤0.01% |
8,724
+2,933
| +51% | +$8.29K |
|
5878
Immuneering
IMRX
$327M
| $28K | ﹤0.01% |
+11,294
| New | +$16.4K |
|
|
ITOS
5879
DELISTED
iTeos Therapeutics
ITOS
| $28K | ﹤0.01% |
2,760
+318
| +13% | +$4.85K |
|
5880
Lightbridge
LTBR
$317M
| $28K | ﹤0.01% |
10,023
+8,413
| +523% | +$24.4K |
|
5881
Lexeo Therapeutics
LXEO
$397M
| $28K | ﹤0.01% |
3,153
+2,186
| +226% | +$26.1K |
|
5882
Oil States International
OIS
$539M
| $28K | ﹤0.01% |
5,968
-229
| -4% | -$1.1K |
|
5883
D-Wave Quantum Inc. Common Stock
QBTS
$7.88B
| $28K | ﹤0.01% |
28,017
-13,171
| -32% | -$13.2K |
|
5884
Rigel Pharmaceuticals
RIGL
$795M
| $28K | ﹤0.01% |
1,725
-4,013
| -70% | -$47.2K |
|
5885
Sutro Biopharma
STRO
$340M
| $28K | ﹤0.01% |
828
+58
| +8% | +$2.27K |
|
5886
Trevi Therapeutics
TRVI
$2.63B
| $28K | ﹤0.01% |
8,271
+2,729
| +49% | +$8.11K |
|
5887
Eaton Vance Short Duration Municipal Income ETF
EVSM
$788M
| $28K | ﹤0.01% |
+553
| New | +$27.7K |
|
|
RNTX
5888
Rein Therapeutics
RNTX
$68.9M
| $28K | ﹤0.01% |
8,000
-52,241
| -87% | -$140K |
|
|
QQQN
5889
DELISTED
VictoryShares Nasdaq Next 50 ETF
QQQN
| $28K | ﹤0.01% |
908
-8,732
| -91% | -$257K |
|
5890
Akebia Therapeutics
AKBA
$242M
| $27K | ﹤0.01% |
20,821
+755
| +4% | +$1.01K |
|
5891
Aldeyra Therapeutics
ALDX
$94.1M
| $27K | ﹤0.01% |
4,871
+185
| +4% | +$881 |
|
5892
AerSale
ASLE
$280M
| $27K | ﹤0.01% |
5,180
-11,124
| -68% | -$64.2K |
|
|
DGICB
5893
Donegal Group Class B
DGICB
$895M
| $27K | ﹤0.01% |
2,078
| – | – |
|
5894
Definitive Healthcare
DH
$68.2M
| $27K | ﹤0.01% |
6,105
-75,647
| -93% | -$355K |
|
5895
Design Therapeutics
DSGN
$928M
| $27K | ﹤0.01% |
4,923
+1,970
| +67% | +$9.27K |
|
5896
Foghorn Therapeutics
FHTX
$372M
| $27K | ﹤0.01% |
2,842
-6,534
| -70% | -$47.3K |
|
|
GGZ
5897
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$128M
| $27K | ﹤0.01% |
2,211
-25,489
| -92% | -$302K |
|
5898
LanzaTech
LNZA
$70.3M
| $27K | ﹤0.01% |
137
+27
| +25% | +$4.42K |
|
5899
Pangaea Logistics
PANL
$487M
| $27K | ﹤0.01% |
3,791
-32
| -0.8% | -$221 |
|
5900
PodcastOne
PODC
$95.7M
| $27K | ﹤0.01% |
17,671
+17,598
| +24,107% | +$26.8K |
|
Similar funds
Royal Bank of Canada's Q3 2024 Portfolio in Review
As of Q3 2024, Royal Bank of Canada held 7,780 positions worth $490B, up 12% from $439B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $18.7B of net new capital in Q3 2024, opening 357 new positions and adding to 3,344 existing holdings. Its largest new stake was Smurfit Westrock: 741,254 shares worth $36.6M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.55B trimmed.
- Royal Bank of Canada's largest Q3 2024 buy was Smurfit Westrock: 741,254 shares worth $36.6M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.39B increase.
- Royal Bank of Canada's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.55B.
- Royal Bank of Canada fully exited WestRock Company in Q3 2024, selling an estimated $13.8M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $490B portfolio in Q3 2024.
- Royal Bank of Canada opened 357 new positions and closed 777 in Q3 2024.
- Royal Bank of Canada's portfolio value rose 12% quarter-over-quarter to $490B.
Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.